SAPHO syndrome
SAPHO syndrome | |
DiseasesDB | 30718 |
---|
WikiDoc Resources for SAPHO syndrome |
Articles |
---|
Most recent articles on SAPHO syndrome Most cited articles on SAPHO syndrome |
Media |
Powerpoint slides on SAPHO syndrome |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on SAPHO syndrome at Clinical Trials.gov Trial results on SAPHO syndrome Clinical Trials on SAPHO syndrome at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on SAPHO syndrome NICE Guidance on SAPHO syndrome
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on SAPHO syndrome Discussion groups on SAPHO syndrome Patient Handouts on SAPHO syndrome Directions to Hospitals Treating SAPHO syndrome Risk calculators and risk factors for SAPHO syndrome
|
Healthcare Provider Resources |
Causes & Risk Factors for SAPHO syndrome |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
SAPHO syndrome is thought to comprise a spectrum of disorders that share some clinical, radiologic and pathologic characteristics. An entity known as chronic recurrent multifocal osteomyelitis (CRMO) was first described in 1972. Subsequently in 1978 several cases of CRMO were associated with clinical findings of palmoplantar pustulosis. Since then, a number of associations between skin conditions and osteoarticular disorders have been reported with a variety of different names including sternocostoclavicular hyperostosis, pustulotic arthro-osteitis, and acne-associated spondyloarthropathy. SAPHO was coined in 1987 and basically represents a spectrum of inflammatory osteitis which may or may not be associated with dermatologic pathology.
Definition
- Synovitis
- Acne -- commonly involving the face and upper back.
- Pustulosis -- usually involving the palms of the hands and/or soles of the feet (palmo-plantar pustulosis).
- Hyperostosis
- Osteitis
Radiologic Findings
Anterior chest wall (most common site, 65-90% of pts): Hyperostosis, sclerosis and bone hypertrophy especially involving the sternoclavicular joint, often with a soft tissue component.
Above images demonstrate sclerosis and hyperostosis of the medial left clavicle (sternocostoclavicular hyperostosis), a very typical site of involvement in the SAPHO syndrome.
Spine (second most common site, 33% of pts): Segmental, usually involving the thoracic spine. 4 main presentations include spondylodiscitis, osteosclerosis, paravertebral ossifications, and sacroiliac joint involvement.
Long bones (30% of pts): usually metadiaphyseal and located in the distal femur and proximal tibia. It looks like chronic osteomyelitis but will not have a sequestrum or abscess.
Flat bones: mandible and ilium (10% of pts).
Peripheral arthritis has been reported in 92% of cases of SAPHO as well.
Children: There is a predilection for the metaphysis of long bones in the legs (tibia, femur, fibula), followed by clavicles and spine.
Treatment
Treatment of patients with SAPHO syndrome is based on clinical symptoms. Generally, treatment involves non-steroidal antiinflammatory drugs and corticosteroid medications (either in the form of topical creams, tablets, or by injection into the involved area). Topical cold applications may also help in affected areas. If unsuccessful, both sulfasalazine and methotrexate have been tried with mixed results.
References
- SAPHO Syndrome by Mike Chang, M.D., University of Washington Department of Radiology
- Skeletal Radiology. 2003 Jun;32(6):311-27.
- MedicineNet.com
Treamtment with anti-TNF have been tried in few paitents with limited success.